Privia Health Group (NASDAQ:PRVA – Get Free Report) is one of 233 publicly-traded companies in the “Healthcare Providers & Services” industry, but how does it contrast to its competitors? We will compare Privia Health Group to related businesses based on the strength of its valuation, analyst recommendations, earnings, dividends, profitability, risk and institutional ownership.
Analyst Ratings
This is a summary of recent recommendations and price targets for Privia Health Group and its competitors, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Privia Health Group | 0 | 3 | 9 | 0 | 2.75 |
| Privia Health Group Competitors | 1867 | 7742 | 13367 | 827 | 2.55 |
Privia Health Group currently has a consensus target price of $31.25, suggesting a potential upside of 29.99%. As a group, “Healthcare Providers & Services” companies have a potential upside of 12.67%. Given Privia Health Group’s stronger consensus rating and higher probable upside, equities research analysts plainly believe Privia Health Group is more favorable than its competitors.
Valuation & Earnings
This table compares Privia Health Group and its competitors top-line revenue, earnings per share and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Privia Health Group | $2.43 billion | $22.92 million | 92.46 |
| Privia Health Group Competitors | $19.10 billion | $301.67 million | 6.94 |
Privia Health Group’s competitors have higher revenue and earnings than Privia Health Group. Privia Health Group is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.
Profitability
This table compares Privia Health Group and its competitors’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Privia Health Group | 1.43% | 4.20% | 2.38% |
| Privia Health Group Competitors | -8.06% | -136.93% | -1.64% |
Institutional & Insider Ownership
94.5% of Privia Health Group shares are owned by institutional investors. Comparatively, 56.7% of shares of all “Healthcare Providers & Services” companies are owned by institutional investors. 5.7% of Privia Health Group shares are owned by company insiders. Comparatively, 15.0% of shares of all “Healthcare Providers & Services” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Risk & Volatility
Privia Health Group has a beta of 0.76, suggesting that its share price is 24% less volatile than the S&P 500. Comparatively, Privia Health Group’s competitors have a beta of 0.98, suggesting that their average share price is 2% less volatile than the S&P 500.
Summary
Privia Health Group beats its competitors on 8 of the 13 factors compared.
Privia Health Group Company Profile
Privia Health Group, Inc. is a physician enablement company that partners with independent medical groups, health systems and other providers. Its technology-enabled platform is designed to help physicians manage their practices and deliver coordinated care, while retaining their clinical independence. The company provides practice management, technology, care coordination and population health services. It also helps providers participate in value-based care arrangements, which tie payments more closely to the quality and efficiency of care.
Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.
